Design to come?

WP_Post Object
(
    [ID] => 1036
    [post_author] => 3
    [post_date] => 2021-11-03 14:51:11
    [post_date_gmt] => 2021-11-03 19:51:11
    [post_content] => 
    [post_title] => Intensity Therapeutics’ Data on Lead Asset, INT230-6, Accepted for Presentation at Two Major Scientific Clinical Oncology Conferences in November
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => intensity-therapeutics-data-on-lead-asset-int230-6-accepted-for-presentation-at-two-major-scientific-clinical-oncology-conferences-in-november
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2021-11-03 14:51:11
    [post_modified_gmt] => 2021-11-03 19:51:11
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=1036
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)